# Cost-Effectiveness of Second-Generation Antipsychotics and Perphenazine in a Randomized Trial of Treatment for Chronic Schizophrenia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-second-generation-antipsychotics-and-perphenazine-in-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Robert A. Rosenheck,Douglas Leslie,Jody L. Sindelar,Edward Alan Miller,Haiqun Lin,T. Scott Stroup,Joseph McEvoy,Sonia M. Davis,Richard S.E. Keefe,Marvin S. Swartz,Diana O. Perkins,John Hsiao,Jeffrey A. Lieberman |
| Citations | 275 |
| DOI | 10.1176/ajp.2006.163.12.2080 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2133198672 |
| PMID | 17151158 |
| Type | article |
| Year | 2006 |

## Paper authors

- [Robert A. Rosenheck](https://scholariq.org/researchers/robert-a-rosenheck/)
- [Edward Alan Miller](https://scholariq.org/researchers/edward-alan-miller/)

## Paper primary topic

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)

## Paper topics

- [Schizophrenia research and treatment](https://scholariq.org/topics/schizophrenia-research-and-treatment/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Parkinson's Disease and Spinal Disorders](https://scholariq.org/topics/parkinson-s-disease-and-spinal-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.